MP Materials’ Earnings Call Contradictions: 10X Facility’s Full Contract vs. Surging Demand and Uncertain Magnet Production Timelines

Date of Call: Aug 6, 2026

Financials Results

• Revenue: $126.1 million, more than doubling last year's revenue, driven primarily by a 127% increase in NDPR sales volumes
• EPS: Adjusted diluted EPS improved $0.12 to a loss of $0.01 per share

Guidance:

• Q3 NDPR realized pricing expected in the high 90s per kilogram, with PPA income roughly $10 per kilogram, leading to a slight sequential decline in overall PPA income.
• Q3 material segment sales volumes expected to be flattish sequentially.
• Magnetics segment to begin initial commercial magnet deliveries in the fourth quarter, with capacity ramping over following quarters.
• Full-year 2026 CapEx expected in the $500 to $600 million range.
• Q3 NDPR production expected to exceed 1,000 metric tons.

Business Commentary:

Strong Quarterly Execution and Production Growth:

• MP Materials produced 840 metric tons of NDPR in Q2, marking a 41% year-over-year increase.
• Despite an extended planned plant shutdown in April, the company met production objectives and improved throughput.
• The growth is attributed to scaling production, broadening product portfolio, and advancements in commercial magnet manufacturing.

Revenue and EBITDA Improvement:

• The materials segment generated $113.2 million in revenue plus PPA income and $32.5 million in adjusted EBITDA, a $45 million year-over-year improvement.
• The increase was driven by a 127% year-over-year increase in NDPR sales volumes, reflecting strong customer demand.

Advancements in Heavy Rare Earth Separation:

• The company is actively commissioning its heavy rare earth separation circuit and expects to begin shipping product from Mountain Pass to Independence later in the year.
• This initiative is part of a strategy to expand the heavy rare earth product portfolio and capitalize on attractive returns.

Progress in Magnetics and Customer Qualification:

• Startup and customer qualification activities at Independence are advancing, with magnets delivered to GM for testing.
• The company expects to begin commercial shipments in the fourth quarter, supported by precursor production margins exceeding 40%.

Expansion and Strategic Partnerships:

• Construction of the 10X facility is accelerating, with foundation work underway and long lead equipment ordered.
• The expansion is driven by strong demand for secure, large-scale magnet manufacturing and strategic partnerships with the Department of War.

Sentiment Analysis:

Overall Tone: Positive

• Statements include: "This was another strong quarter of execution...", "customer demand continues to outpace our production growth", "strong financial performance", "We are making very meaningful progress...", "I am incredibly proud of what we have accomplished...", "Our partnership... continues to advance", "We remain very much on track."

Q&A:

• Question from Lawson Winder (Bank of America Securities): Regarding the new defense contract for gadolinium, is this the first of many, how does it work (pricing), and why gadolinium?
  Response: It is an example of many to come; economics are locked in with attractive returns, and volumes can grow at significant incremental returns. Gadolinium was a logical first product to maximize value from the heavy rare earth circuit.

• Question from George Giannarikis (Canaccord Genuity): How is the domestic shortage of specialized talent impacting your ability to scale 10X and other facilities?
  Response: Talent acquisition is challenging but manageable; the company focuses on being an employer of choice and has built momentum to attract people.

• Question from George Giannarikis (Canaccord Genuity): How are allocation conversations for 10X capacity progressing regarding pricing structure and prepayments?
  Response: Demand is high; the company has the ability to be patient and selective, and Project Swarm helps coordinate demand for national security applications.

• Question from Brian Lee (Goldman Sachs & Co.): What is the capacity and economics for other heavy rare earth offtakes beyond the new gadolinium deal?
  Response: Opportunities exist for samarium, yttrium, and follow-on volumes in gadolinium, with significant demand and potential for attractive returns due to controlled scarcity.

• Question from Max Ural (BMO): Is the recent U.S. ban on exporting magnet scrap changing your thinking on recycling capacity?
  Response: Recycling has been part of the strategy; the ban highlights its importance, and there is significant interest, but the primary focus is on processing waste from own operations and supporting Apple.

• Question from Richard Garchitoreno (Barclays): Will commissioning the heavy rare earth circuit add costs in H2, and how much could costs improve?
  Response: Investments like maintenance and staffing are apparent; cost improvements will come from scaling production, process efficiency, and bringing chloralkali online, building progressively through 2027.

• Question from Richard Garchitoreno (Barclays): Should we expect a stronger cadence of new contracts given increasing demand?
  Response: NDPR remains the binding constraint; the company is in a strong position to be patient and selective in contracting, similar to the strategy with the recent gadolinium announcement.

• Question from Corinne Blanchard (Deutsche Bank): How should we think about material segment performance and costs going into Q3 and Q4?
  Response: Demand remains strong; Q3 sales volumes likely flattish sequentially, with future growth requiring filling the channel as production scales.

• Question from Corinne Blanchard (Deutsche Bank): What is the impact of the China export ban on reagent costs?
  Response: Minimal impact expected due to long-term supply chain resilience planning.

• Question from Carlos De Ab Alba (Morgan Stanley): What is the status of GM magnet qualification and testing?
  Response: Progress is extremely encouraging; the team is meeting all customer requirements, with regular production deliveries expected in Q4.

• Question from Carlos De Ab Alba (Morgan Stanley): Can you provide more color on the planned reagent trial and its benefits?
  Response: The trial is expected to improve water quality and provide operational benefits; the reagent change will have a higher direct cost but overall benefits are expected to outweigh it.

• Question from Bill Peterson (J.P. Morgan): How does tightness of multiple materials inform your expectations for procuring heavies and potential acquisitions?
  Response: The company has flexibility with third-party feedstocks and a designed separation circuit for various heavies; demand for no-heavy magnets is growing, especially in robotics and disk drives.

• Question from Derek Ma (TD Cowen): Why haven't we seen an acceleration in new magnetics contracts despite strong demand signals?
  Response: Independence and 10X are already heavily contracted; the company is in no rush to announce deals and will do so when ready to maximize long-term value.

• Question from Matt Somerville (DA Davidson): What is the expected phasing of the magnetics commercial ramp in H2 and 2027?
  Response: Ramp will be lumpy and nonlinear; initial commercial deliveries in Q4 with a modest volume increase, aligning with customer production needs.

• Question from Matt Somerville (DA Davidson): What is the current and future NDPR demand from the U.S. defense complex?
  Response: Current defense demand is relatively immaterial, but drone production could become a significant demand driver in 3-5 years as China's exports are restricted.

• Question from Ben Kala (Baird): What is being done to lead innovation in response to scarcity?
  Response: Innovation focuses on reducing costs and thrifting materials, with a team dedicated to evolving magnet formulas and manufacturing processes to adapt to market changes.

Contradiction Point 1

Operational Moat and Competitive Advantage

Contradiction on the scale and nature of the company's competitive advantages.

Lawson Winder (Bank of America Securities) - Lawson Winder (Bank of America Securities)

2026Q2: The company sees incremental return opportunities by growing volumes over time. - Ryan Corbett(CFO)

What is the significance of the new defense contract for gadolinium, including whether it's the first of many, how pricing linkage works, and the importance of gadolinium being the first mineral? - George Gianarikas (Canaccord Genuity)

2026Q1: Litinsky expressed skepticism about new projects being brought online as quickly or cheaply as projected due to the long lead times, high costs, and technical challenges involved. - Jim Litinsky(CEO)

Contradiction Point 2

Timeline for Reaching Full Production Capacity

Contradiction on the expected timeline to achieve full operational run rates at key facilities.

Matt Somerville (DA Davidson) - Matt Somerville (DA Davidson)

2026Q2: Commercial magnet shipments are expected to start in Q4 with a modest ramp, aligned with customer plant demand. - Ryan Corbett(CFO)

What are the expected factors impacting magnetics revenue/EBITDA in H2 and the timeline for scaling up to 1,000 tons per year at 10X? - Lawson Winder (Bank of America Securities) - Follow-up

2026Q1: The ultimate goal is for MP to 'leap ahead' and become the best magnet maker in the world from an IP standpoint by the time 10X comes online. - Jim Litinsky(CEO)

Contradiction Point 3

Status of 10X Facility Contract Filling

Inconsistent portrayal of whether the 10X facility is already sold out or still being filled.

Derick Ma (TD Cowen) - Derick Ma (TD Cowen)

2026Q2: The 10X facility is 100% contracted with the Department of Defense. - James Litinsky(CEO)

Why hasn't strong demand translated into accelerated magnetics contracts for Independence and 10X, and what's needed to convert signals into firm agreements? - George Gianarikas (Canaccord Genuity) - Follow-up:

2026Q2: The company is in a position to be patient and selective, as demand far exceeds the capacity of the 10X facility. - Ryan Corbett(CFO)

Contradiction Point 4

Pace and Rationale for Announcing New Contracts

Conflicting statements on urgency and strategy behind contract announcements.

Derek Ma (TD Cowen) - Derek Ma (TD Cowen)

2026Q2: The company is in no rush to announce deals, as the value of its platform is becoming increasingly apparent. It will announce when ready. - Jim Litinsky(CEO)

Why haven't new magnetics contracts accelerated despite strong security of supply concerns, and what needs to happen for demand signals to translate into firm contracts? - George Giannarikis (Canaccord Genuity) - Follow-up:

2026Q2: The company is in a strong position to be patient due to high demand visibility... It sees an opportunity to be a 'kingmaker' in certain verticals. - Jim Litinsky(CEO)

Contradiction Point 5

Future Demand and Pricing Outlook for NdPr

Contradiction on the primary driver of future NdPr price increases.

What did Richard Garchitoreno (Barclays) highlight in the earnings call? - Richard Garchitoreno (Barclays)

2026Q2: The company remains conviction that NDPR is the binding constraint globally... As physical AI use cases grow, demand could spike dramatically... - Jim Litinsky(CEO)

What is the impact of commissioning the DyTb circuit and April maintenance on H2 costs, and how much could costs improve in the second half? - Brian Lee (Goldman Sachs)

20260227-2025 Q4: ...The pace of physical AI development will create further upward pressure. - James Litinsky(CEO)